<DOC>
	<DOCNO>NCT02295787</DOCNO>
	<brief_summary>The investigator study plan investigate feasibility efficacy repeat dos intranasal ketamine severely depressed patient least 65 year age experience suicidal ideation . The result study could lead development new strategy treat depression .</brief_summary>
	<brief_title>Intranasal Ketamine Late-Life Depression Suicidal Ideation</brief_title>
	<detailed_description />
	<mesh_term>Depression</mesh_term>
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Suicide</mesh_term>
	<mesh_term>Suicidal Ideation</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<criteria>1 ) ≥65 year old , 2 ) provide write informed consent , 3 ) meet criterion primary psychiatric diagnosis major depressive disorder accord Structured Clinical Interview DSMIV ( SCID ) HDRS28 total score ≥20 ; depression may start time point life , certain comorbid diagnosis ( e.g. , anxiety disorder ) allow insofar primary psychiatric diagnosis , 4 ) history ≥2 fail medication trial current episode ( per Massachusetts General Hospital Antidepressant Treatment History Questionnaire ; MGH ATRQ ) , 5 ) endorse suicidal ideation 2 month , per Columbia Suicide Severity Rating Scale ( CSSRS ) HDRS28 suicide item score ≥1 ( thought life n't worth live ) , 6 ) stable antidepressant regimen ≥14 day prior Study Phase II , 7 ) maintain treat psychiatrist agreement study participation , 8 ) reliable chaperone accompany home follow completion intranasal administration . Patients exclude follow criterion meet : 1 ) Delirium dementia diagnosis , 2 ) unstable medical illness , 3 ) history clinically significant cardiovascular disease electrocardiogram ( EKG ) finding , medical condition put patient risk possible cardiac side effect , 4 ) history multiple adverse drug reaction , 5 ) current/past history psychotic disorder homicidality , 6 ) active substance use disorder ( except nicotine caffeine ) within past six month , positive urine toxicology screen , past history ketamine abuse , 7 ) requirement exclude medication ( narcotic , barbiturate , theophylline , St. John 's Wort ) , 8 ) concurrent recent participation research study .</criteria>
	<gender>All</gender>
	<minimum_age>65 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Depression</keyword>
	<keyword>Suicide</keyword>
	<keyword>Suicidal Ideation</keyword>
	<keyword>Ketamine</keyword>
	<keyword>Late-Life</keyword>
</DOC>